Today's Pre-Market Movers and Top Ratings | COST, DG, BMBL, HPQ and More

$Bristol-Myers Squibb (BMY.US)$ Shares jumped 3.8% after the FDA approved Cobenfy as a new treatment for schizophrenia in adults, marking the first novel treatment for the mental disorder in several decades.

$Wynn Resorts (WYNN.US)$ Shares climbed 1.7% following an upgrade to overweight from equal weight by Morgan Stanley, which highlighted the company's strong fundamentals compared to its competitors.

$Novo-Nordisk A/S (NVO.US)$ U.S.-listed shares slid 3.4% following a JPMorgan advisory that projected third-quarter sales to fall below Wall Street expectations, partly due to a tepid forecast for its weight-loss drug Wegovy.

$Costco (COST.US)$ Shares dipped about 0.9% after the company reported fiscal fourth-quarter revenue of $79.70 billion, missing the analyst average estimate of $79.97 billion due to cautious consumer spending and falling gasoline prices.

$Super Micro Computer (SMCI.US)$ Shares slipped 0.84%, adding to a 12% loss in the previous session, after reports of a Justice Department probe following allegations of accounting manipulation by Hindenburg Research.

$Dollar General (DG.US)$ Shares fell 1.9% after being downgraded to sell from neutral by Citi, which cited increasing competitive pressure from Walmart’s pricing strategy.

$Bumble (BMBL.US)$ Shares fell 2.3% after a downgrade to sector weight from overweight by KeyBanc, due to weak app store data and future risks.

$HP Inc (HPQ.US)$ Shares fell about 3.0% following a downgrade to neutral from buy at Bank of America, which noted the company’s reliance on stock buybacks to support future earnings growth.